Lonza Group AG (OTCMKTS:LZAGY – Free Report) – Research analysts at William Blair issued their FY2026 earnings estimates for shares of Lonza Group in a research report issued to clients and investors on Wednesday, January 29th. William Blair analyst M. Smock expects that the company will earn $2.03 per share for the year. The consensus estimate for Lonza Group’s current full-year earnings is $1.83 per share.
LZAGY has been the topic of several other research reports. Redburn Atlantic raised Lonza Group to a “strong-buy” rating in a report on Wednesday, November 27th. The Goldman Sachs Group upgraded shares of Lonza Group to a “strong-buy” rating in a research note on Wednesday, October 9th.
Lonza Group Price Performance
LZAGY opened at $63.41 on Monday. Lonza Group has a 1-year low of $48.96 and a 1-year high of $67.00. The business has a 50 day moving average of $60.47 and a 200-day moving average of $62.05. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.04 and a quick ratio of 1.38.
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Featured Articles
- Five stocks we like better than Lonza Group
- P/E Ratio Calculation: How to Assess Stocks
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- How to Invest in Small Cap StocksÂ
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- The 3 Best Fintech Stocks to Buy Now
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
